Woman files Yaz lawsuit against birth control manufacturer
An Illinois woman has filed a Yaz lawsuit against the birth control pill’s manufacturer, alleging that the drugs caused her to develop dangerous blood clots. Mindy Verson claims in her lawsuit that German manufacturer Bayer is responsible for the injuries she sustained from Yaz.
Bayer has paid $142 million to settle Yaz and Yasmin lawsuits
The manufacturer of the birth control pills Yaz and Yasmin announced last week that it has paid $142 million to settle lawsuits alleging that the two drugs caused blood clots and other serious injuries. Bayer Pharmaceuticals said in a report that it is settling Yasmin and Yaz lawsuits involving venous clot injuries, including pulmonary embolism, [...]
Bayer will pay $110 M to settle Yaz lawsuits
Bayer Pharmaceuticals—the manufacturer of Yaz and Yasmin—will pay at least $110 million to settle lawsuits alleging that the birth control pills caused potentially fatal blood clots. The money will settle about 500 of more than 11,000 Yasmin and Yaz lawsuits against the German drug maker.
FDA announces strong blood clots warning for Yaz and Yasmin
The Food and Drug Administration has issued a warning that the birth control pills Yaz and Yasmin can increase the risk of blood clots compared to other birth control pills. In a statement announcing the new Yasmin and Yaz warning, the FDA stated that patients may be up to three times more likely to suffer [...]
New Jersey Yaz lawsuit surpasses 1,200 plaintiffs
More than 1,200 patients have joined a New Jersey Yaz lawsuit alleging that side effects from the birth control drug caused them injuries. Women involved in the lawsuit allege that Bayer Pharmaceuticals failed to warn patients about the increased risks of blood clots and other side effects associated with Yaz.
Woman files Yasmin lawsuit against manufacturer
A North Dakota woman has filed a Yaz and Yasmin lawsuit against the birth control pills’ manufacturer. Donna Praus alleges that Bayer Pharmaceuticals failed to warn patients about the increased risks of blood clots associated with taking Yaz and Yasmin.
Birth control coverage debate ignores side effects risks, critics say
Activists in the debate to provide female employees with birth control under the 2010 Affordable Care Act have expressed concerns about the safety of the contraceptives being provided. The Obama administration announced in February 2012 women employed at religious institutions will be eligible to receive free birth control from their insurance company.
Online survey marketed Yaz, Yasmin to women with PMS
Bayer Pharmaceuticals—the manufacturer of Yaz and Yasmin birth control pills—may have used an online survey in order to increase demand for the drug among women. The survey listed a number of symptoms of premenstrual dysphoric disorder (PMDD) which could be confused with those affecting women with premenstrual syndrome (PMS).
FDA approves three generic versions of Yaz birth control pills
The Food and Drug Administration has approved three generic versions of Yaz. The generics—marketed and sold as Gianvi, Loryna and Vestura—received an AB rating from the FDA, meaning the drugs are equivalent to Yaz, Bayer Pharmaceutical’s top-selling birth control pill.
FDA panel member deny conflict of interest in Yaz and Yasmin vote
Two members of a Food and Drug Administration panel to review the safety of Yaz and Yasmin denied that they had a conflict of interest in their recent committee vote to keep the drugs on the market. Paula Hillard and Julia Johnson acknowledged having ties to the manufacturer of the drugs they were assigned to [...]